Methylene Chloride

Methylene Chloride

SCHEMBL27418043

COCCNC(=O)CSC.ClCCl

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.48
HPGD P15428 7/20 0.44
HTT P42858 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TSHR P16473 2/20 0.43
ALDH1A1 P00352 4/20 0.42
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 3/20 0.41
GLA P06280 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 1/20 0.40
CA2 P00918 1/20 0.40
GAA P10253 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CYP2C9 P11712 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7534487 0.94 POLB (0.51) POLBHPGDHTTHSD17B10TSHR
SCHEMBL227856 0.80
SCHEMBL20863205 0.76 TSHR (0.53) POLBHPGDHTTTSHRALDH1A1
SCHEMBL12592614 0.74 LMNA (0.43) POLBHPGDHTTHSD17B10TSHR
SCHEMBL23478140 0.73 TSHR (0.65) POLBHPGDHTTTSHRALDH1A1
SCHEMBL10104241 0.73 KMT2A (0.48) HTTHSD17B10TSHRALDH1A1KDM4E
SCHEMBL15697747 0.73 MEN1 (0.42) POLBHPGDHSD17B10TSHRALDH1A1
SCHEMBL4814439 0.71
SCHEMBL310766 0.71
SCHEMBL3187649 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1088992-C Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders ALCON LAB INC (US) 2002-08-14 CN disclosed
CN-1129397-A Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders ALCON LAB INC (US) 1996-08-21 CN disclosed